\BOOKMARK [0][-]{Doc-Start}{Curriculum Vitae}{}% 1
\BOOKMARK [0][-]{Doc-Start}{Abstract}{}% 2
\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 3
\BOOKMARK [1][-]{section.1.1}{A Primer on Microbial Ecology}{chapter.1}% 4
\BOOKMARK [2][-]{subsection.1.1.1}{Background and motivation}{section.1.1}% 5
\BOOKMARK [2][-]{subsection.1.1.2}{Methodology for the study of microbiomes}{section.1.1}% 6
\BOOKMARK [1][-]{section.1.2}{The Skin Microbiome}{chapter.1}% 7
\BOOKMARK [2][-]{subsection.1.2.1}{Healthy skin microbiomes}{section.1.2}% 8
\BOOKMARK [2][-]{subsection.1.2.2}{Dermatological disease-state microbiomes}{section.1.2}% 9
\BOOKMARK [2][-]{subsection.1.2.3}{Chronic wounds}{section.1.2}% 10
\BOOKMARK [1][-]{section.1.3}{The Viral Fraction of the Microbiome}{chapter.1}% 11
\BOOKMARK [2][-]{subsection.1.3.1}{Background and motivation}{section.1.3}% 12
\BOOKMARK [2][-]{subsection.1.3.2}{Methodology for the study of viromes}{section.1.3}% 13
\BOOKMARK [2][-]{subsection.1.3.3}{The virome in health and disease}{section.1.3}% 14
\BOOKMARK [1][-]{section.1.4}{Outlook}{chapter.1}% 15
\BOOKMARK [1][-]{section.1.5}{Dissertation Overview}{chapter.1}% 16
\BOOKMARK [1][-]{section.1.6}{Permissions and Attributions}{chapter.1}% 17
\BOOKMARK [0][-]{chapter.2}{Improved single-swab sample preparation for recovering bacterial and phage DNA from human skin and wound microbiomes}{}% 18
\BOOKMARK [1][-]{section.2.1}{Abstract}{chapter.2}% 19
\BOOKMARK [1][-]{section.2.2}{Introduction}{chapter.2}% 20
\BOOKMARK [1][-]{section.2.3}{Results}{chapter.2}% 21
\BOOKMARK [2][-]{subsection.2.3.1}{Recovery of phage and bacterial DNA released from swabs}{section.2.3}% 22
\BOOKMARK [2][-]{subsection.2.3.2}{Amount of DNA released from swabs}{section.2.3}% 23
\BOOKMARK [2][-]{subsection.2.3.3}{Limit of detection of phage swabbed from human skin}{section.2.3}% 24
\BOOKMARK [2][-]{subsection.2.3.4}{Recovery of T4 and bacterial DNA from skin swabs}{section.2.3}% 25
\BOOKMARK [2][-]{subsection.2.3.5}{Recovery of bacterial and phage DNA from clinical wound and skin swabs}{section.2.3}% 26
\BOOKMARK [1][-]{section.2.4}{Discussion}{chapter.2}% 27
\BOOKMARK [1][-]{section.2.5}{Conclusion}{chapter.2}% 28
\BOOKMARK [1][-]{section.2.6}{Methods}{chapter.2}% 29
\BOOKMARK [2][-]{subsection.2.6.1}{Phage and bacterial sample preparation}{section.2.6}% 30
\BOOKMARK [2][-]{subsection.2.6.2}{Swabbing from human skin}{section.2.6}% 31
\BOOKMARK [2][-]{subsection.2.6.3}{Fractionation of virus-like particles \(VLPs\)}{section.2.6}% 32
\BOOKMARK [2][-]{subsection.2.6.4}{Isolation of DNA from virus-like particles}{section.2.6}% 33
\BOOKMARK [2][-]{subsection.2.6.5}{Extraction of genomic DNA from the remainder fraction and unfractionated samples}{section.2.6}% 34
\BOOKMARK [2][-]{subsection.2.6.6}{Collection, processing, and quantification of clinical samples}{section.2.6}% 35
\BOOKMARK [2][-]{subsection.2.6.7}{Quantitative PCR}{section.2.6}% 36
\BOOKMARK [2][-]{subsection.2.6.8}{16S rRNA library preparation, sequencing, and bioinformatics}{section.2.6}% 37
\BOOKMARK [2][-]{subsection.2.6.9}{VLP-enriched library preparation, sequencing, and bioinformatics}{section.2.6}% 38
\BOOKMARK [0][-]{chapter.3}{Microbial predictors of healing and short-term effect of debridement on the microbiome of chronic wounds: the role of facultative anaerobes}{}% 39
\BOOKMARK [1][-]{section.3.1}{Abstract}{chapter.3}% 40
\BOOKMARK [1][-]{section.3.2}{Introduction}{chapter.3}% 41
\BOOKMARK [1][-]{section.3.3}{Results}{chapter.3}% 42
\BOOKMARK [2][-]{subsection.3.3.1}{Bacterial composition of skin and chronic wound microbiomes}{section.3.3}% 43
\BOOKMARK [2][-]{subsection.3.3.2}{Differences in abundance of individual bacterial taxa in skin vs. chronic wound microbiomes}{section.3.3}% 44
\BOOKMARK [2][-]{subsection.3.3.3}{Minimal changes to the chronic wound microbiome immediately after debridement}{section.3.3}% 45
\BOOKMARK [2][-]{subsection.3.3.4}{Healing and non-healing wounds exhibit similar immediate response to debridement}{section.3.3}% 46
\BOOKMARK [2][-]{subsection.3.3.5}{Differential abundance of facultative anaerobes in healed vs. unhealed wounds}{section.3.3}% 47
\BOOKMARK [1][-]{section.3.4}{Discussion}{chapter.3}% 48
\BOOKMARK [2][-]{subsection.3.4.1}{Limitations}{section.3.4}% 49
\BOOKMARK [1][-]{section.3.5}{Conclusion}{chapter.3}% 50
\BOOKMARK [1][-]{section.3.6}{Methods}{chapter.3}% 51
\BOOKMARK [2][-]{subsection.3.6.1}{Ethics statement}{section.3.6}% 52
\BOOKMARK [2][-]{subsection.3.6.2}{Collection of clinical samples}{section.3.6}% 53
\BOOKMARK [2][-]{subsection.3.6.3}{Sample processing \046 DNA extraction}{section.3.6}% 54
\BOOKMARK [2][-]{subsection.3.6.4}{Library preparation \046 sequencing}{section.3.6}% 55
\BOOKMARK [2][-]{subsection.3.6.5}{16S rRNA bioinformatic analyses}{section.3.6}% 56
\BOOKMARK [2][-]{subsection.3.6.6}{Diversity and differential abundance analyses}{section.3.6}% 57
\BOOKMARK [2][-]{subsection.3.6.7}{Bayesian generalized linear mixed model}{section.3.6}% 58
\BOOKMARK [0][-]{chapter.4}{The Chronic Wound Virome and its Associations with Bacterial Communities and Healing Outcomes}{}% 59
\BOOKMARK [1][-]{section.4.1}{Abstract}{chapter.4}% 60
\BOOKMARK [1][-]{section.4.2}{Introduction}{chapter.4}% 61
\BOOKMARK [1][-]{section.4.3}{Results}{chapter.4}% 62
\BOOKMARK [2][-]{subsection.4.3.1}{Read processing and classification summary}{section.4.3}% 63
\BOOKMARK [2][-]{subsection.4.3.2}{Skin and wound viromes are dominated by bacteriophages targeting pathogens and commensals}{section.4.3}% 64
\BOOKMARK [2][-]{subsection.4.3.3}{Wounds exhibit greater viral diversity than skin}{section.4.3}% 65
\BOOKMARK [2][-]{subsection.4.3.4}{Skin and wound viromes are taxonomically distinct}{section.4.3}% 66
\BOOKMARK [2][-]{subsection.4.3.5}{Viral species are associated with healing outcomes}{section.4.3}% 67
\BOOKMARK [2][-]{subsection.4.3.6}{Specific viral species are associated with skin and wound samples}{section.4.3}% 68
\BOOKMARK [2][-]{subsection.4.3.7}{Phage abundances are both positively and negatively correlated to host abundances}{section.4.3}% 69
\BOOKMARK [1][-]{section.4.4}{Discussion}{chapter.4}% 70
\BOOKMARK [2][-]{subsection.4.4.1}{Limitations}{section.4.4}% 71
\BOOKMARK [1][-]{section.4.5}{Conclusion}{chapter.4}% 72
\BOOKMARK [1][-]{section.4.6}{Methods}{chapter.4}% 73
\BOOKMARK [2][-]{subsection.4.6.1}{Ethics Statement}{section.4.6}% 74
\BOOKMARK [2][-]{subsection.4.6.2}{Clinical sample collection}{section.4.6}% 75
\BOOKMARK [2][-]{subsection.4.6.3}{Sample processing and DNA extraction}{section.4.6}% 76
\BOOKMARK [2][-]{subsection.4.6.4}{Isolation of DNA from virus-like particles}{section.4.6}% 77
\BOOKMARK [2][-]{subsection.4.6.5}{Library preparation and sequencing of VLP DNA}{section.4.6}% 78
\BOOKMARK [2][-]{subsection.4.6.6}{Viral read pre-processing}{section.4.6}% 79
\BOOKMARK [2][-]{subsection.4.6.7}{Taxonomic read classification and abundance estimation}{section.4.6}% 80
\BOOKMARK [2][-]{subsection.4.6.8}{Viral community composition and differential abundance analyses}{section.4.6}% 81
\BOOKMARK [2][-]{subsection.4.6.9}{16S rRNA library preparation, sequencing and bioinformatics}{section.4.6}% 82
\BOOKMARK [2][-]{subsection.4.6.10}{Phage-host correlations}{section.4.6}% 83
\BOOKMARK [0][-]{chapter.5}{Conclusion, Future Directions, and Closing Remarks}{}% 84
\BOOKMARK [0][-]{appendix.A}{Appendix}{}% 85
\BOOKMARK [1][-]{section.A.1}{Supplemental Information}{appendix.A}% 86
\BOOKMARK [2][-]{subsection.A.1.1}{Supplemental Tables}{section.A.1}% 87
\BOOKMARK [2][-]{subsection.A.1.2}{Supplemental Figures}{section.A.1}% 88
\BOOKMARK [2][-]{subsection.A.1.3}{Discussion of modeling methods}{section.A.1}% 89
\BOOKMARK [1][-]{section.A.2}{Abbreviations}{appendix.A}% 90
